944 studies found for:    Open Studies | "Rectal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Condition: Stage III Colon Cancer
Intervention: Biological: AVX701
22 Recruiting Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer
Conditions: Colorectal Cancer;   Hepatic Metastasis
Intervention: Other: Evaluate the correlation of overall different objective response.
23 Recruiting Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Procedure: Colorectal cancer surgery
24 Recruiting L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases
Conditions: Colon Carcinoma;   Rectum Carcinoma
Interventions: Biological: L-BLP25;   Biological: Placebo
25 Recruiting Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
Condition: Metastatic Colorectal Cancer
26 Unknown  The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study
Condition: Rectal Cancer
Intervention: Radiation: Patient Position During Radiotherapy
27 Recruiting Treatment Of Chronic Anal Fissure
Condition: Chronic Anal Fissure
Interventions: Other: Levorag Emulgel;   Drug: Diltiazem
28 Recruiting First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer Stage II
Intervention: Drug: Bevacizumab and FOLFIRI
29 Not yet recruiting A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence
Condition: Colorectal Cancer (CRC)
30 Unknown  XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
Conditions: Rectal Neoplasms;   Locally Advanced Rectal Adenocarcinoma
Intervention: Drug: bevacizumab
31 Recruiting wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients
Condition: Colorectal Cancer
Interventions: Drug: wXELIRI regimen;   Drug: FOLFIRI regimen
32 Recruiting Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
Condition: Colorectal Cancer
Interventions: Radiation: preoperative radiation therapy;   Drug: Valproic Acid;   Drug: Capecitabine
33 Recruiting Effect of Sacral Nerve Stimulation on Enteric Nervous System
Condition: Fecal Incontinence
Intervention: Procedure: Sacral nerve stimulation
34 Unknown  Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial
Condition: Colorectal Cancer
Intervention: Drug: Aprepitant /  Fosaprepitant
35 Not yet recruiting Study to Compare and Evaluate the Pharmacokinetic (PK) and Safety Profile of Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) as First-line Treatment in Patients With Metastatic ColoRectal Cancer (mCRC)
Condition: Metastatic Colorectal Cancer.
Interventions: Drug: Experimental: Bevacizumab biosimilar (BEVZ92).;   Drug: Active Comparator: Avastin® (bevacizumab, reference product)
36 Recruiting A Trial Evaluating Raltitrexed, Oxaliplatin and Bevacizumab Combination Versus FOLFOX6 Plus Bevacizumab in 2nd-line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: bevacizumab, oxaliplatin and 5FU combination;   Drug: Bevacizumab, oxaliplatin and raltitrexed combination
37 Recruiting Chemoradiation or Brachytherapy for Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: Endo-HDR (if randomized to this arm);   Drug: capecitabine and IMRT (if randomized to this arm);   Radiation: IMRT (intensity modulated radiation therapy);   Drug: FOLFOX6;   Procedure: Surgery
38 Unknown  Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
Condition: Colorectal Cancer
Interventions: Drug: capecitabine;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin
39 Unknown  Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
Conditions: Colorectal Cancer;   Liver Metastases;   Irradiation Damage;   Radiation Induced Liver Disease
Interventions: Drug: Pentoxifylline;   Drug: Ursodeoxycholic Acid;   Drug: Enoxaparin
40 Recruiting A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Panitumumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years